Actively Recruiting

Early Phase 1
Age: 18Years +
All Genders
NCT06828588

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Led by Vanderbilt-Ingram Cancer Center · Updated on 2026-05-08

30

Participants Needed

1

Research Sites

189 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to determine if the radiotracer, \[68Ga\]Ga-ABY-025, used for PET imaging can help us better identify and visualize lesions or tumors, in patients who are receiving standard of care therapy HER2+ cancers.

CONDITIONS

Official Title

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Patients with unresectable locally advanced or metastatic cancer eligible for standard HER2-targeted therapy with FDA-approved indication
  • Planning to start or recently started HER2-targeted therapy with no more than 6 cycles completed
  • Previous biopsy showing HER2 expression or amplification in at least one lesion
  • Measurable disease outside the liver on CT, FDG-PET, or MRI for RECIST evaluation
  • Life expectancy of at least 6 months
  • Patients with brain metastases are allowed
Not Eligible

You will not qualify if you...

  • Measurable disease only in the liver
  • Unable to comply with study procedures
  • Allergy or hypersensitivity to any component of [68Ga]Ga-ABY-025
  • Pregnant or breastfeeding
  • HER2-negative cancers without FDA-approved HER2-directed therapy indication
  • Unable to lie flat for 30 minutes during imaging
  • Medical or psychiatric conditions that prevent successful study participation per treating physician

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232

Actively Recruiting

Loading map...

Research Team

M

Makenna Brown

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy | DecenTrialz